ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia-Reference-Cited by-同舟云学术

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Published:2017-05-11 Issue:13 Volume:1 Page:792-801
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Faulkner Lawrence¹²,Uderzo Cornelio¹,Khalid Sadaf¹,Marwah Priya³,Soni Rajpreet³,Yaqub Naila⁴,Amanat Samina⁴,Fatima Itrat⁴,Gilani Sarah Khan⁴,Zahra Tatheer⁴,Ramprakash Stalin²,Gooneratne Lallindra⁵,Dissanayake Ruwangi⁵,Williams Senani⁶,Rathnayake Wasantha⁶,Srinivas Reshma⁷,Sedai Amit⁷,Kumari Ankita⁷,Parmar Lailith⁷,Dhanya Rakesh⁷,Agarwal Rajat Kumar⁷

Affiliation:

1. Cure2Children Foundation, Florence, Italy;

2. People Tree Hospitals, Bangalore, India;

3. South East Asia Institute for Thalassemia, Jaipur, India;

4. Children’s Hospital Pakistan Institute of Medical Sciences, Islamabad, Pakistan;

5. Asiri Central Hospital, Colombo, Sri Lanka;

6. Nawaloka Hospital, Colombo, Sri Lanka; and

7. Sankalp India Foundation, Bangalore, India

Abstract

Key Points In low-risk BMT for thalassemia, ATG-BuCy seems as effective as Tt-BuCy in the prevention of rejection and may decrease transplant-related mortality.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/13/792/877195/advances004119.pdf

Reference63 articles.

1. The inherited diseases of hemoglobin are an emerging global health burden;Weatherall;Blood,2010

2. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations;de Silva;Lancet,2000

3. Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan;Ho;Bone Marrow Transplant,2006

4. How I treat thalassemia;Rachmilewitz;Blood,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uniform graft-versus-host disease prophylaxis using post-transplantation cyclophosphamide, methotrexate, and cyclosporine following peripheral blood hematopoietic stem cell transplantation from matched and haploidentical donors for transfusion-dependent thalassemia: a retrospective report from the BMF-WG of Hunan province, China;Transplantation and Cellular Therapy;2024-09

2. Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression;Bone Marrow Transplantation;2024-02-07

3. Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for Thalassemia;Transplantation and Cellular Therapy;2023-07

4. Is Old (Fludrabine/Busulfan/Cyclophosphamide/rAntiThymocyteGlobulin) Conditioning Still Gold for Allogeneic Transplants in Transfusion Dependent Beta-Thalassemia of All Risk Categories in 21st Century?;Indian Journal of Hematology and Blood Transfusion;2023-04-03

5. Role of Anti-thymocyte Globulin in Stem Cell Transplant;Basics of Hematopoietic Stem Cell Transplant;2023